Literature DB >> 22367717

Translating the brain transcriptome in neuroAIDS: from non-human primates to humans.

Jessica M Winkler1, Amrita Datta Chaudhuri, Howard S Fox.   

Abstract

In the post-human genome project era, high throughput techniques to detect and computational algorithms to analyze differentially expressed genes have proven to be powerful tools for studying pathogenesis of neuroAIDS. Concurrently, discovery of non-coding RNAs and their role in development and disease has underscored the importance of examining the entire transcriptome instead of protein coding genes alone. Herein, we review the documented changes in brain RNA expression profiles in the non-human primate model of neuroAIDS (SIV infected monkeys) and compare the findings to those resulting from studies in post-mortem human samples of neuroAIDS. Differential expression of mRNAs involved in inflammation and immune response are a common finding in both monkey and human samples - even in HIV infected people on combination antiretroviral therapy, a shared set of genes is upregulated in the brains of both infected monkeys and humans: B2M, IFI44, IFIT3, MX1, STAT1. Additionally, alterations in ion channel encoding genes have been observed in the human studies. Brain miRNA profiling has also been performed, and up-regulation of two miRNAs originating from the same transcript, miR-142-3p and miR-142-5p, is common to human and monkey neuroAIDS studies. With increases in knowledge about the genome and advances in technology, unraveling alterations in the transcriptome in the SIV/monkey model will continue to enrich our knowledge about the effects of HIV on the brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367717      PMCID: PMC3354039          DOI: 10.1007/s11481-012-9344-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  49 in total

1.  A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Authors:  Mary Jane Potash; Wei Chao; Galina Bentsman; Nicolae Paris; Manisha Saini; Jadwiga Nitkiewicz; Paula Belem; Leroy Sharer; Andrew I Brooks; David J Volsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

2.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

3.  Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques.

Authors:  M von Herrath; M B Oldstone; H S Fox
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

4.  CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE).

Authors:  Eleanor S Roberts; Eleizer Masliah; Howard S Fox
Journal:  J Neuropathol Exp Neurol       Date:  2004-12       Impact factor: 3.685

5.  Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis.

Authors:  Eliezer Masliah; Eleanor S Roberts; Dianne Langford; Ian Everall; Leslie Crews; Anthony Adame; Edward Rockenstein; Howard S Fox
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

6.  Acquired neuronal channelopathies in HIV-associated dementia.

Authors:  Benjamin B Gelman; Vicki M Soukup; Kimberly W Schuenke; Michael J Keherly; Charles Holzer; Frances J Richey; Christopher J Lahart
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

7.  Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS.

Authors:  Eleanor S Roberts; E M E Burudi; Claudia Flynn; Lisa J Madden; Kelli L Roinick; Debbie D Watry; Michelle A Zandonatti; Michael A Taffe; Howard S Fox
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

8.  Cognitive and motor impairments associated with SIV infection in rhesus monkeys.

Authors:  E A Murray; D M Rausch; J Lendvay; L R Sharer; L E Eiden
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

Review 9.  Simian immunodeficiency virus: a model for neuroAIDS.

Authors:  H S Fox; L H Gold; S J Henriksen; F E Bloom
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

10.  Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Susan Morgello; Wei Chao; Seon-Young Kim; Andrew I Brooks; Jacinta Murray; Mary Jane Potash; David J Volsky
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more
  22 in total

Review 1.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

2.  Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.

Authors:  Andrew J Levine; Austin Quach; David J Moore; Cristian L Achim; Virawudh Soontornniyomkij; Eliezer Masliah; Elyse J Singer; Benjamin Gelman; Natasha Nemanim; Steve Horvath
Journal:  J Neurovirol       Date:  2015-12-21       Impact factor: 2.643

3.  Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1.

Authors:  Rebeca Geffin; Ricardo Martinez; Roberto Perez; Biju Issac; Micheline McCarthy
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-07       Impact factor: 4.147

4.  Commentary: Animal models of neuroAIDS.

Authors:  Howard S Fox; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-02       Impact factor: 4.147

Review 5.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

6.  Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques.

Authors:  Liz Simon; Keijing Song; Curtis Vande Stouwe; Andrew Hollenbach; Angela Amedee; Mahesh Mohan; Peter Winsauer; Patricia Molina
Journal:  J Neuroimmune Pharmacol       Date:  2015-11-25       Impact factor: 4.147

7.  Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.

Authors:  Richard Danger; Chloé Paul; Magali Giral; Amélie Lavault; Yohann Foucher; Nicolas Degauque; Annaïck Pallier; Maxim Durand; Stéphanie Castagnet; Jean-Paul Duong Van Huyen; Michel Delahousse; Karine Renaudin; Jean-Paul Soulillou; Sophie Brouard
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

8.  Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.

Authors:  Andrew J Levine; Jeremy A Miller; Paul Shapshak; Benjamin Gelman; Elyse J Singer; Charles H Hinkin; Deborah Commins; Susan Morgello; Igor Grant; Steve Horvath
Journal:  BMC Med Genomics       Date:  2013-02-13       Impact factor: 3.063

9.  Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system.

Authors:  Jonathan Liu; Jeanne M Sisk; Lucio Gama; Janice E Clements; Kenneth W Witwer
Journal:  Mol Brain       Date:  2013-09-02       Impact factor: 4.041

10.  MicroRNA-142 reduces monoamine oxidase A expression and activity in neuronal cells by downregulating SIRT1.

Authors:  Amrita Datta Chaudhuri; Sowmya V Yelamanchili; Howard S Fox
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.